title: Accelerated discovery of novel benzodiazepine ligands by experiment-guided virtual screening.
abstract: High throughput discovery of ligand scaffolds for target proteins can accelerate development of leads and drug candidates enormously. Here we describe an innovative workflow for the discovery of high affinity ligands for the benzodiazepine-binding site on the so far not crystallized mammalian GABAA receptors. The procedure includes chemical biology techniques that may be generally applied to other proteins. Prerequisites are a ligand that can be chemically modified with cysteine-reactive groups, knowledge of amino acid residues contributing to the drug-binding pocket, and crystal structures either of proteins homologous to the target protein or, better, of the target itself. Part of the protocol is virtual screening that without additional rounds of optimization in many cases results only in low affinity ligands, even when a target protein has been crystallized. Here we show how the integration of functional data into structure-based screening dramatically improves the performance of the virtual screening. Thus, lead compounds with 14 different scaffolds were identified on the basis of an updated structural model of the diazepam-bound state of the GABAA receptor. Some of these compounds show considerable preference for the α3β2γ2 GABAA receptor subtype.
authors: Institute of Biochemistry and Molecular Medicine, University of Bern , CH-3012 Bern, Switzerland.
authors: Simon J
authors: SJ
authors: Middendorp
authors: Roshan
authors: R
authors: Puthenkalam
authors: Roland
authors: R
authors: Baur
authors: Margot
authors: M
authors: Ernst
authors: Erwin
authors: E
authors: Sigel
mesh_terms: D001569:Benzodiazepines / Q000378:metabolism*; D004353:Drug Evaluation, Preclinical; D008024:Ligands
chemical_list: D008024:Ligands; D001569:Benzodiazepines